Tumor cell secreted-PLAU promotes the conversion of fibroblasts to iCAFs that facilitate the expression and secretion of IL8 via uPAR/Akt/NF-κB, and this activity can be can be blocked by a PLAU-uPAR inhibitor (IPR-803). This evidence concerns the gene AKT1 and neoplasm.